Aim and Scope
The Journal of Oncology Therapeutics and Drug Development is a peer-reviewed, open-access journal committed to advancing scientific research and innovation in the development of anticancer therapies. The journal serves as an international platform for the publication of high-quality research, breakthrough discoveries, and emerging therapeutic approaches that contribute to improved cancer treatment, drug discovery, and clinical outcomes.
The journal covers a comprehensive range of topics related to oncology therapeutics and drug development, including but not limited to:
-
Oncology Drug Discovery and Design
-
Targeted Cancer Therapies
-
Immuno-Oncology and Immune-Based Treatments
-
Pharmaceutical Sciences and Anticancer Agents
-
Nanotechnology and Advanced Drug-Delivery Systems
-
Preclinical and Translational Oncology Research
-
Clinical Trials and Therapeutic Evaluation
-
Cancer Biomarkers and Precision Medicine
-
Molecular Oncology and Mechanism-Based Drug Development
-
Radiopharmaceuticals and Novel Therapeutic Modalities
-
Toxicology, Pharmacokinetics, and Pharmacodynamics
-
Combination Therapies and Resistance Mechanisms
-
Regulatory Science and Drug Approval Pathways
The journal publishes original research articles, reviews, short communications, case studies, clinical trial reports, and expert perspectives that meaningfully advance the understanding and development of innovative cancer therapeutics.
The Journal of Oncology Therapeutics and Drug Development aims to foster collaboration among oncologists, pharmaceutical scientists, researchers, clinicians, industry experts, and policymakers to accelerate the discovery and delivery of effective cancer treatments worldwide. By promoting scientific excellence and knowledge exchange, the journal strives to support the global effort to reduce the burden of cancer through enhanced drug development and therapeutic innovation.